at the division focuses on an analysis
of the realisation and regulation of
function from genetic information. The
tumour material is
at the centre of attention, with an emphasis on pancreatic
complement the molecular analyses with functional
studies for the
relevant cellular mechanisms and the
identification and evaluation
of potential therapeutic avenues.
Beside the creation of scientific
and medical knowledge, we work at the
development and refinement of
appropriate methods and technologies. One aim in
this respect is the establishment of means for
an early and non-invasive
diagnosis, reliable patient
and a precise monitoring of treatment results.
promising developments are ongoing in the field of proteome
analysis. We have established affinity-based processes of a
and reproducibility that meet the requirements of clinical applications
amendable to translation. A scientific goal is a quantitative description of protein
interactions, in particular for the identification of variations
a personal level. Another objective is is the
creation of a map of the
protein-mediated communication between the different cell types of the
tumour microenvironment. A third
activity aims at the
disease-specific protein isoforms; structural variation is often an
for functional differences.
For a functional understanding, both targeted experiments and global
studies are pursued. An example of the former is a detailed analysis of the
activating effect on expression of methylation in gene promoters; for the latter, genome-wide shRNA knock-down or CRISPR-Cas
mediated knockout studies and related over-expression
analyses are performed.
Another line of work aims at
the fully synthetic, in
vitro implementation of complex biological processes.
Motivation is their utilization in synthetic
biology activities for the
production of biomedically active
molecules, such as non-immunogenic agents, and the establishment of an
artificial molecular system. Cell-free biosynthetic production will be
for mastering many biotechnological and pharmacochemical challenges.
biological systems will complement Systems Biology by evaluating
models experimentally. Similar to physics, insight into cellular
be gained by an iterative process of performing experimental and
Systems Biology. Eventually, this may lead to the establishment of a
synthetic self-replicating system and, ultimately, an archetypical
model of a
Since recently, we are also active in the area of Molecular
Epidemiology, with a
particular emphasis on melanoma and breast cancer. Projects include
or epigenetic variations through genotyping or sequencing of primary
risk of developing advanced disease.
projects are pursued in
national and international collaborations and programmes. Apart from publications in
scientific journals, the division filed a substantial number of patents, of which
several have been licensed out or are being
ongoing collaborations with commercial partners. Also, several
been spun-off, which utilise some of the results at a commercial level.